1. Home
  2. CPIX vs PFX Comparison

CPIX vs PFX Comparison

Compare CPIX & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.04

Market Cap

92.3M

Sector

Health Care

ML Signal

HOLD

PFX

PhenixFIN Corporation

N/A

Current Price

$43.18

Market Cap

85.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
PFX
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
92.3M
85.5M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
PFX
Price
$6.04
$43.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.5K
515.0
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
3.57%
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$38.30
52 Week High
$7.36
$53.59

Technical Indicators

Market Signals
Indicator
CPIX
PFX
Relative Strength Index (RSI) 52.55 52.35
Support Level $5.42 $43.01
Resistance Level $6.61 $44.56
Average True Range (ATR) 0.48 0.62
MACD -0.05 -0.16
Stochastic Oscillator 35.24 46.05

Price Performance

Historical Comparison
CPIX
PFX

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: